Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer

L Garland; L A Robinson; H Wagner

Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer

Chest Surg Clin N Am. 2001 Feb;11(1):69-100, viii.

Authors

L Garland¹, L A Robinson, H Wagner

Affiliation

¹ Thoracic Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida, USA.

PMID: 11253602

Abstract

Management of the stage IIIA (N2) patient remains one of the most controversial areas in thoracic oncology. The potential curability of at least some of these patients has encouraged the development of more complex, aggressive, and toxic multimodality treatment regimens.

Publication types

Review

MeSH terms

Carcinoma, Non-Small-Cell Lung / pathology*
Carcinoma, Non-Small-Cell Lung / therapy*
Combined Modality Therapy
Diagnostic Imaging
Humans
Lung Neoplasms / pathology*
Lung Neoplasms / therapy*
Lymphatic Metastasis
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasm Staging